AC Immune raises CHF 20 million and initiates world's first anti-pTau vaccine trial for Alzheimer's disease
09.January 2014 08:00 CET
- CHF 20 million round D secured from existing investors
- World's first Alzheimer's vaccine trial against phospho-Tau hallmark